IDEAYA Prices $300 Mln Offering Of Stock And Warrants; Stock Down

IDEAYA Biosciences priced an underwritten public offering of 5.56 million shares at $27.00 per share, alongside pre-funded warrants to purchase up to 5.56 million additional shares. The deal increases share count and may create mild dilution pressure, though it also boosts the company's balance sheet. The announcement is likely to weigh on the stock modestly in the near term.

Analysis

IDEAYA Biosciences priced an underwritten public offering of 5.56 million shares at $27.00 per share, alongside pre-funded warrants to purchase up to 5.56 million additional shares. The deal increases share count and may create mild dilution pressure, though it also boosts the company's balance sheet. The announcement is likely to weigh on the stock modestly in the near term.